From September 15 to 18, 2025, GC Genome, a South Korean leader in genomic diagnostics, held a series of seminars in Bahrain and Saudi Arabia to promote its innovative multi-cancer early detection service, ai-CANCERCH. The events, which focused on forging strategic partnerships with key regional institutions, marked a significant step in the company’s expansion into the rapidly growing Middle Eastern healthcare market.In Bahrain, GC Genome collaborated with BioLab, a prominent local diagnostics provider, to showcase ai-CANCERCH’s capabilities. The seminar drew interest from representatives o
Pharma & Biotech
Kim Kuk Ju, HEALTH IN NEWS TEAM
2025.09.25 17:34
